Oligometastatic Lung Cancer

Posted On 2023-04-26 10:52:03
Oligometastatic Lung Cancer
Editors: Jianxing He, Matthias Guckenberger, Salma K. Jabbour

Publisher: AME Publishing Company; 1st edition (2023)
ISBN: 978-988-74594-5-3
Hardcover: 258 pages
Language: English
Available at:

This book titled “Oligometastatic Lung Cancer” is a collection of articles contributed by renowned experts in this field from leading centers of excellence around the world and it provides a comprehensive review of various aspects of oligometastatic NSCLC. There are three main sections, including research status, epidemiology, and treatment of oligometastatic NSCLC. In the first section, the authors cover various aspects of clinical and translational research in eight articles. The second section includes an article on the epidemiology of oligometastatic NSCLC based on a systematic review and pooled analysis. The last section is further divided into subsections including surgery, ablative therapy, radiotherapy, and ablative radiotherapy, immunotherapy, and local consolidative therapy. The five articles in the surgery subsection cover the evidence for surgery for oligometastatic NSCLC, appropriate surgical candidate selection, surgical approaches, the surgeon’s role in oligometastatic NSCLC, and clinically prognostic factors in surgically treated patients, respectively. The next section on ablative therapy includes three articles with one editorial on ablative therapy for oligometastatic NSCLC. The other two articles are narrative reviews on local ablative therapy for oligometastatic NSCLC and local ablative therapy for oncogenic driven oligometastatic NSCLC, respectively. In the radiotherapy section, there are two articles covering the role and the changing landscape of radiotherapy in oligometastatic NSCLC. Subsequent section on ablative radiotherapy includes four articles covering the role of SBRT in oligometastatic NSCLC including for consolidation. The section on immunotherapy includes an article on the optimization of immunotherapy in trials for oligometastatic NSCLC. The final section which is on local consolidative therapy includes six articles addressing this topic.


David E. Gerber Department Internal Medicine (Hematology-Oncology) and the O’Donnell School of Public Health, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Simon S. Lo Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA


Jianxing He The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, China; Guangzhou Respiratory Health Research Institute, China
Matthias Guckenberger Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Salma K. Jabbour Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA


Marcelo F. Jimenez Service of Thoracic Surgery, Salamanca University Hospital, IBSAL, Salamanca, Spain
Tomoyuki Hishida Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan